Report cover image

Global Brain Tumor Diagnosis and Treatment Market Size Study, by Product Type (Primary Brain Tumor, Secondary Brain Tumor), by Product Analysis (Stains & Varnishes, Shellacs, Lacquers, Others), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testi

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20179360

Description

The Global Brain Tumor Diagnosis and Treatment Market is currently valued at approximately USD 0.60 billion in 2024 and is projected to expand at a robust compound annual growth rate (CAGR) of 8.222% during the forecast period from 2024 to 2034. Brain tumors, characterized by abnormal cell growth within the brain, pose significant diagnostic and therapeutic challenges. The market for diagnosing and treating brain tumors is being revolutionized by technological advancements and enhanced precision tools. These innovations have enabled healthcare professionals to detect tumors at an earlier stage, refine treatment protocols, and improve patient outcomes.

The remarkable growth in this market is driven by rising incidence rates of brain tumors, coupled with increasing awareness of the latest diagnostic and treatment methods. Advanced imaging techniques such as MRI and PET-CT scans have become the cornerstone of accurate diagnoses, providing detailed insights into tumor size, location, and malignancy. Simultaneously, treatment modalities like immunotherapy and targeted therapy are rapidly gaining traction, offering personalized solutions that minimize side effects and improve survival rates.

Moreover, substantial investments in healthcare infrastructure and research have amplified the availability of sophisticated diagnostic tools and therapeutic options. Government initiatives and funding for cancer research are bolstering this market, enabling the development of innovative technologies and expanding access to cutting-edge treatments. However, challenges such as the high cost of advanced diagnostic equipment and treatment procedures may hinder market growth. Additionally, the complex nature of brain tumor pathophysiology necessitates a multidisciplinary approach, adding to the intricacies of management.

Regionally, North America dominates the market, driven by well-established healthcare infrastructure, high investment in cancer research, and a strong presence of key industry players. Europe follows closely, with robust R&D activities and growing adoption of advanced diagnostic and treatment solutions. Meanwhile, the Asia-Pacific region is anticipated to witness the fastest growth rate due to increasing healthcare spending, rising awareness about early diagnosis, and improving access to advanced medical technologies.

Major market players included in this report are:
  • Roche Diagnostics
  • Siemens Healthineers
  • General Electric (GE) Healthcare
  • Canon Medical Systems Corporation
  • Medtronic plc
  • Elekta AB
  • Varian Medical Systems, Inc.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Amgen Inc.
  • Novartis AG
  • AbbVie Inc.
  • Philips Healthcare
  • Bayer AG
The detailed segments and sub-segment of the market are explained below:

By Product Type:
  • Primary Brain Tumor
  • Secondary Brain Tumor
By Product Analysis:
  • Stains & Varnishes
  • Shellacs
  • Lacquers
  • Others
By Diagnosis Type:
  • CT Scan
  • MRI
  • PET-CT Scan
  • Molecular Testing
  • EEG
  • Others
By Treatment Type:
  • Surgery
  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
By End User:
  • Hospitals
  • Ambulatory Surgical Centers
By Region:

North America:
  • U.S.
  • Canada
Europe:
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America
Middle East & Africa:
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2024
  • Forecast period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand-side and supply-side analysis of the market.

Table of Contents

285 Pages
Chapter 1. Global Brain Tumor Diagnosis and Treatment Market Executive Summary
1.1. Global Brain Tumor Diagnosis and Treatment Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Product Analysis
1.3.3. By Diagnosis Type
1.3.4. By Treatment Type
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
Chapter 2. Global Brain Tumor Diagnosis and Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Brain Tumor Diagnosis and Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Incidence of Brain Tumors
3.1.2. Advancements in Diagnostic Technologies
3.1.3. Rising Investments in Healthcare Infrastructure
3.2. Market Challenges
3.2.1. High Cost of Advanced Diagnostic Equipment
3.2.2. Complexity of Brain Tumor Pathophysiology
3.3. Market Opportunities
3.3.1. Expansion of Personalized Medicine
3.3.2. Innovations in Treatment Modalities
3.3.3. Government Initiatives and Funding
Chapter 4. Global Brain Tumor Diagnosis and Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Product Type 2024-2034
5.1. Segment Dashboard
5.2. Global Brain Tumor Diagnosis and Treatment Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Primary Brain Tumor
5.2.2. Secondary Brain Tumor
Chapter 6. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Product Analysis 2024-2034
6.1. Segment Dashboard
6.2. Global Brain Tumor Diagnosis and Treatment Market: Product Analysis Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Stains & Varnishes
6.2.2. Shellacs
6.2.3. Lacquers
6.2.4. Others
Chapter 7. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Diagnosis Type 2024-2034
7.1. Segment Dashboard
7.2. Global Brain Tumor Diagnosis and Treatment Market: Diagnosis Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. CT Scan
7.2.2. MRI
7.2.3. PET-CT Scan
7.2.4. Molecular Testing
7.2.5. EEG
7.2.6. Others
Chapter 8. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Treatment Type 2024-2034
8.1. Segment Dashboard
8.2. Global Brain Tumor Diagnosis and Treatment Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Surgery
8.2.2. Radiation Therapy
8.2.3. Targeted Therapy
8.2.4. Chemotherapy
8.2.5. Immunotherapy
Chapter 9. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by End User 2024-2034
9.1. Segment Dashboard
9.2. Global Brain Tumor Diagnosis and Treatment Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
Chapter 10. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Region 2024-2034
10.1. North America Brain Tumor Diagnosis and Treatment Market
10.1.1. U.S. Brain Tumor Diagnosis and Treatment Market
10.1.1.1. Product Type Breakdown Size & Forecasts, 2024-2034
10.1.1.2. Product Analysis Breakdown Size & Forecasts, 2024-2034
10.1.2. Canada Brain Tumor Diagnosis and Treatment Market
10.2. Europe Brain Tumor Diagnosis and Treatment Market
10.2.1. UK Brain Tumor Diagnosis and Treatment Market
10.2.2. Germany Brain Tumor Diagnosis and Treatment Market
10.2.3. France Brain Tumor Diagnosis and Treatment Market
10.2.4. Spain Brain Tumor Diagnosis and Treatment Market
10.2.5. Italy Brain Tumor Diagnosis and Treatment Market
10.2.6. Rest of Europe Brain Tumor Diagnosis and Treatment Market
10.3. Asia-Pacific Brain Tumor Diagnosis and Treatment Market
10.3.1. China Brain Tumor Diagnosis and Treatment Market
10.3.2. India Brain Tumor Diagnosis and Treatment Market
10.3.3. Japan Brain Tumor Diagnosis and Treatment Market
10.3.4. Australia Brain Tumor Diagnosis and Treatment Market
10.3.5. South Korea Brain Tumor Diagnosis and Treatment Market
10.3.6. Rest of Asia-Pacific Brain Tumor Diagnosis and Treatment Market
10.4. Latin America Brain Tumor Diagnosis and Treatment Market
10.4.1. Brazil Brain Tumor Diagnosis and Treatment Market
10.4.2. Mexico Brain Tumor Diagnosis and Treatment Market
10.4.3. Rest of Latin America Brain Tumor Diagnosis and Treatment Market
10.5. Middle East & Africa Brain Tumor Diagnosis and Treatment Market
10.5.1. Saudi Arabia Brain Tumor Diagnosis and Treatment Market
10.5.2. South Africa Brain Tumor Diagnosis and Treatment Market
10.5.3. Rest of Middle East & Africa Brain Tumor Diagnosis and Treatment Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Roche Diagnostics
11.1.2. Siemens Healthineers
11.1.3. General Electric (GE) Healthcare
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Roche Diagnostics
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Medtronic plc
11.3.3. Elekta AB
11.3.4. Varian Medical Systems, Inc.
11.3.5. Pfizer Inc.
11.3.6. Johnson & Johnson Services, Inc.
11.3.7. Merck & Co., Inc.
11.3.8. Amgen Inc.
11.3.9. Novartis AG
11.3.10. AbbVie Inc.
11.3.11. Philips Healthcare
11.3.12. Bayer AG
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us